Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Oncogene
|
August 9, 2011
Sox2 expression in breast tumours and activation in breast cancer stem cells
O Leis, A Eguiara, E Lopez-Arribillaga, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 20, 2016
Prospective Phase II Trial of Once-weekly Hypofractionated Radiation Therapy for Low-risk Adenocarcinoma of the Prostate: Late Toxicities and Outcomes
M Zimmermann, D Taussky, C Menkarios, et al.
Prostate Cancer and Prostatic Diseases
|
October 2, 2013
RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients
L A Kachnic, S L Pugh, P Tai, et al.
Clinical and Translational Radiation Oncology
|
March 6, 2023
Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial
M M Beaudry, D Carignan, W Foster, et al.
The Journal of Dermatological Treatment
|
September 24, 2002
A comparative trial of two retinoids commonly used in the treatment of acne vulgaris
J Nyirady, R M Grossman, M Nighland, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 27, 2016
Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data
A Loblaw, T Pickles, J Crook, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 9, 2025
Ultra-hypofractionated radiotherapy combined with HDR brachytherapy: An optimized treatment
I Sidibé, M M Beaudry, D Carignan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 10, 2025
A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087)
G Morton, E Vigneault, M Barkati, et al.
Journal of the American Academy of Dermatology
|
June 19, 1998
Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail
M R Ling, L J Swinyer, M T Jarratt, et al.
Journal of the American Academy of Dermatology
|
June 19, 1998
Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail
R C Savin, L Drake, D Babel, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Oncogene
|
August 9, 2011
Sox2 expression in breast tumours and activation in breast cancer stem cells
O Leis, A Eguiara, E Lopez-Arribillaga, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 20, 2016
Prospective Phase II Trial of Once-weekly Hypofractionated Radiation Therapy for Low-risk Adenocarcinoma of the Prostate: Late Toxicities and Outcomes
M Zimmermann, D Taussky, C Menkarios, et al.
Prostate Cancer and Prostatic Diseases
|
October 2, 2013
RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients
L A Kachnic, S L Pugh, P Tai, et al.
Clinical and Translational Radiation Oncology
|
March 6, 2023
Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial
M M Beaudry, D Carignan, W Foster, et al.
The Journal of Dermatological Treatment
|
September 24, 2002
A comparative trial of two retinoids commonly used in the treatment of acne vulgaris
J Nyirady, R M Grossman, M Nighland, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 27, 2016
Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data
A Loblaw, T Pickles, J Crook, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 9, 2025
Ultra-hypofractionated radiotherapy combined with HDR brachytherapy: An optimized treatment
I Sidibé, M M Beaudry, D Carignan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 10, 2025
A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087)
G Morton, E Vigneault, M Barkati, et al.
Journal of the American Academy of Dermatology
|
June 19, 1998
Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail
M R Ling, L J Swinyer, M T Jarratt, et al.
Journal of the American Academy of Dermatology
|
June 19, 1998
Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail
R C Savin, L Drake, D Babel, et al.
Page
of 5